• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

3-Methyl-2-oxobutanoic acid

CAS No. 759-05-7

3-Methyl-2-oxobutanoic acid ( alpha-Ketoisovaleric acid;2-Oxoisovaleric acid )

产品货号. M19994 CAS No. 759-05-7

alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
100MG ¥470 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    3-Methyl-2-oxobutanoic acid
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids.
  • 产品描述
    alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin an acidogen and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. alpha-Ketoisovaleric acid is a keto-acid which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia) urine (organic aciduria) the brain and other tissues lead to general metabolic acidosis.
  • 同义词
    alpha-Ketoisovaleric acid;2-Oxoisovaleric acid
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Others
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    759-05-7
  • 分子量
    116.12
  • 分子式
    C5H8O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:10 mM
  • SMILES
    CC(C)C(=O)C(O)=O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Yudkoff M et al. Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005 Jun;135(6 Suppl):1531S-8S.
产品手册
关联产品
  • Exo-1

    Methyl 3-(4-fluorobenzoyl)-6-methyl-2-pyridinecarboxylate is a chemical compound.

  • RG 14620

    RG14620 is an epidermal growth factor receptor (EGFR) inhibitor.

  • Fmoc-Thr(GlcNAc(Ac)3...

    This amino acid is compatible with standard protocols in Fmoc solid phase peptide synthesis.